Monocyclic Peptides: A Complete Guide to Types, Synthesis, and Therapeutic Applications

Comprehensive review of monocyclic peptide types, synthesis methods, and applications covering their use as bioactive molecules, targeted therapeutics, diagnostics, and vaccine design.

Khazaei-Poul, Yalda et al.·Current pharmaceutical biotechnology·2021·n/a-reviewReview
RPEP-05497Reviewn/a-review2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
n/a-review
Sample
N=N/A (review)
Participants
N/A (literature review)

What This Study Found

Comprehensive review covering monocyclic peptide classification, synthesis methods (chemical and enzymatic), and applications in bioactive molecule design, targeted therapeutics, diagnostics, and vaccine development.

Key Numbers

Covers antimicrobial, anticancer, delivery, diagnostic, and agricultural cyclic peptide applications

How They Did This

Narrative review of monocyclic peptide chemistry, synthesis, and biomedical applications.

Why This Research Matters

Cyclic peptides are one of the fastest-growing drug classes, bridging the gap between small molecules and biologics. Understanding their types and synthesis enables rational design for diverse therapeutic applications.

The Bigger Picture

Monocyclic peptides represent a sweet spot in drug design: large enough for high-specificity protein interactions but small enough for potential oral delivery and tissue penetration. Several are already FDA-approved drugs.

What This Study Doesn't Tell Us

Broad review covering many topics without deep analysis of any single application. Some synthesis methods are technically challenging at scale. Clinical evidence varies widely between applications.

Questions This Raises

  • ?Which monocyclic peptide synthesis method is best suited for clinical manufacturing?
  • ?Can oral delivery of monocyclic peptides be achieved reliably?
  • ?What new therapeutic targets are most suited to monocyclic peptide approaches?

Trust & Context

Key Stat:
Fastest-growing drug class Monocyclic peptides bridge small molecules and biologics with superior stability and selectivity — multiple members are now FDA-approved drugs
Evidence Grade:
Not applicable (comprehensive chemistry review).
Study Age:
Published 2021. Cyclic peptide drug development continues accelerating.
Original Title:
Monocyclic Peptides: Types, Synthesis and Applications.
Published In:
Current pharmaceutical biotechnology, 22(1), 123-135 (2021)
Database ID:
RPEP-05497

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What makes cyclic peptides better than linear ones?

Cyclization (forming a ring) makes peptides more stable against enzymatic degradation, locks them into their bioactive shape, and can improve cell penetration. This means they work better as drugs, lasting longer in the body and binding their targets more tightly.

Are any cyclic peptide drugs already available?

Yes — cyclosporine (immune suppression), daptomycin (antibiotic), and several others are FDA-approved cyclic peptide drugs. Many more are in clinical development for cancer, infectious diseases, and autoimmune conditions.

Read More on RethinkPeptides

Cite This Study

RPEP-05497·https://rethinkpeptides.com/research/RPEP-05497

APA

Khazaei-Poul, Yalda; Farhadi, Shohreh; Ghani, Sepideh; Ahmadizad, Safar Ali; Ranjbari, Javad. (2021). Monocyclic Peptides: Types, Synthesis and Applications.. Current pharmaceutical biotechnology, 22(1), 123-135. https://doi.org/10.2174/1573412916666200120155104

MLA

Khazaei-Poul, Yalda, et al. "Monocyclic Peptides: Types, Synthesis and Applications.." Current pharmaceutical biotechnology, 2021. https://doi.org/10.2174/1573412916666200120155104

RethinkPeptides

RethinkPeptides Research Database. "Monocyclic Peptides: Types, Synthesis and Applications." RPEP-05497. Retrieved from https://rethinkpeptides.com/research/khazaei-poul-2021-monocyclic-peptides-types-synthesis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.